Jalandhar Online

Hypertrophic Scar Market, Epidemiology, and Market Forecast Analysis Research Report

 Breaking News
  • No posts were found

Hypertrophic Scar Market, Epidemiology, and Market Forecast Analysis Research Report

June 29
22:20 2021
Hypertrophic Scar Market, Epidemiology, and Market Forecast Analysis Research Report

DelveInsight Business Research LLP
DelveInsight’s “Hypertrophic Scar Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Hypertrophic Scar, historical and forecasted epidemiology as well as the Hypertrophic Scar market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

What are Hypertrophic Scar?

Hypertrophic Scars are raised, red, rigid, inflexible cell-like, and cosmetic problems precipitated due to multiple underlying dermal injuries such as burn, surgery, and trauma during which aberrant wound healing with more pathological deposition of the extracellular matrix than degradation leads to their spawning.

How Hypertrophic Scar affected population?

Hypertrophic Scar Epidemiology –

  • Females and males have equal risk of developing Hypertrophic Scar.
  • Adolescents and pregnant women may have a greater probability of forming Hypertrophic Scar.
  • Incidence rates of Hypertrophic Scar have been reported as high as 91% following extensive trauma, such as a deep burn injury, suggesting a role for the extent of trauma in their development.

Hypertrophic Scar Market Outlook

According to DelveInsight, Hypertrophic Scar market in 7MM is expected to change in the study period 2017-2030. The key driver for the surge in Hypertrophic Scar market size is the rise in number of incident/prevalent cases. 

Neodyne Biosciences’ Embrace Advanced Scar Therapy System has been approved by the FDA top treat HTSs. It delivers mechano-modulation therapy to the injury site and surrounding tissues. The device includes a simple disposable applicator that transfers a predetermined level of strain to a single use adhesive silicone sheet, which is then adhered over the closed scar. This unique mechanism of action provides a uniform compressive strain, or stress-shield around a closed scar, which can minimize collagen proliferation and formation of scar tissue. The Embrace device was cleared by the FDA in September 2011 and is the only FDA-Cleared scar therapy system designed to relieve tension around incisions, general cuts and lacerations to prevent the formation of new, visible, raised scars before they start.

The Hypertrophic Scar market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Hypertrophic Scar market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

To know more, request sample pages @Hypertrophic Scar Market Landscape

Which are the leading companies in Hypertrophic Scar market?

The pipeline of Hypertrophic scars is quiet weak with few potential key players, such as Henry Ford Health System/ Gladerma, Phio Pharmaceuticals and others. The dynamics of HTS market is anticipated to change in the coming years owing to the improvement in the research and development activities so that market will comprise of efficient treatment options. The launch of emerging therapies is expected during the forecast period of 2020–2030.

Request sample pages for more information on Hypertrophic Scar Market Report

Table of contents

1. Key Insights

2. Executive Summary of Hypertrophic Scar

3. Competitive Intelligence Analysis for Hypertrophic Scar

4. Hypertrophic Scar: Market Overview at a Glance

4.1. Hypertrophic Scar Total Market Share (%) Distribution in 2017

4.2. Hypertrophic Scar Total Market Share (%) Distribution in 2030

5. Hypertrophic Scar: Disease Background and Overview

5.1. Introduction

5.2. Sign and Symptoms 

5.3. Pathophysiology 

5.4. Risk Factors 

5.5. Diagnosis 

6. Hypertrophic Scar Patient Journey

7. Hypertrophic Scar Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale: 7MM

7.3. Epidemiology Scenario: 7MM

7.3.1. Hypertrophic Scar Epidemiology Scenario in the 7MM (2017-2030)

7.4. United States Epidemiology

7.4.1. Hypertrophic Scar Epidemiology Scenario in the United States (2017-2030)

7.5. EU-5 Country-wise Epidemiology

7.5.1. Germany Epidemiology

7.5.1.1. Hypertrophic Scar Epidemiology Scenario in Germany (2017-2030)

7.5.2. France Epidemiology

7.5.2.1. Hypertrophic Scar Epidemiology Scenario in France (2017-2030)

7.5.3. Italy Epidemiology

7.5.3.1. Hypertrophic Scar Epidemiology Scenario in Italy (2017-2030)

7.5.4. Spain Epidemiology

7.5.4.1. Hypertrophic Scar Epidemiology Scenario in Spain (2017-2030)

7.5.5. United Kingdom Epidemiology

7.5.5.1. Hypertrophic Scar Epidemiology Scenario in the United Kingdom (2017-2030)

7.5.6. Japan Epidemiology

7.5.6.1. Hypertrophic Scar Epidemiology Scenario in Japan (2017-2030)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Hypertrophic Scar Treatment and Management

8.2. Hypertrophic Scar Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Hypertrophic Scar Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

List to be continued in report

13. Hypertrophic Scar: Seven Major Market Analysis

13.1. Key Findings

13.2. Hypertrophic Scar Market Size in 7MM

13.3. Hypertrophic Scar Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

15.1.1. Hypertrophic Scar Total Market Size in the United States

15.1.2. Hypertrophic Scar Market Size by Therapies in the United States

15.2. EU-5 countries: Market Size and Outlook

15.3. Germany Market Size

15.3.1. Hypertrophic Scar Total Market Size in Germany

15.3.2. Hypertrophic Scar Market Size by Therapies in Germany

15.4. France Market Size

15.4.1. Hypertrophic Scar Total Market Size in France

15.4.2. Hypertrophic Scar Market Size by Therapies in France

15.5. Italy Market Size

15.5.1. Hypertrophic Scar Total Market Size in Italy

15.5.2. Hypertrophic Scar Market Size by Therapies in Italy

15.6. Spain Market Size

15.6.1. Hypertrophic Scar Total Market Size in Spain

15.6.2. Hypertrophic Scar Market Size by Therapies in Spain

15.7. United Kingdom Market Size

15.7.1. Hypertrophic Scar Total Market Size in the United Kingdom

15.7.2. Hypertrophic Scar Market Size by Therapies in the United Kingdom

15.8. Japan Market Outlook

15.8.1. Japan Market Size

15.8.2. Hypertrophic Scar Total Market Size in Japan

15.8.3. Hypertrophic Scar Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Hypertrophic Scar

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

*The table of contents is not exhaustive; the final content may vary. 

Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/